THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 127 filers reported holding THERAVANCE INC in Q3 2014. The put-call ratio across all filers is 1.82 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $36,000 | -65.0% | 2,545 | -57.7% | 0.00% | – |
Q3 2014 | $103,000 | -96.6% | 6,010 | -94.0% | 0.00% | -100.0% |
Q2 2014 | $3,006,000 | -4.8% | 100,908 | -1.2% | 0.00% | 0.0% |
Q1 2014 | $3,159,000 | -12.8% | 102,133 | +0.5% | 0.00% | -33.3% |
Q4 2013 | $3,622,000 | -15.4% | 101,646 | -2.9% | 0.00% | -25.0% |
Q3 2013 | $4,281,000 | +53.2% | 104,687 | +44.4% | 0.00% | +33.3% |
Q2 2013 | $2,795,000 | – | 72,502 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baupost Group | 20,705,801 | $640,637,000 | 15.48% |
Litespeed Management, L.L.C. | 1,931,554 | $59,762,000 | 6.48% |
Realm Partners LLC | 323,121 | $9,997,000 | 5.75% |
Foundation Asset Management, LP | 612,327 | $18,945,000 | 5.15% |
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,805,937 | $86,816,000 | 3.37% |
Proxima Capital Management, LLC | 513,500 | $15,888,000 | 2.99% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 6,955,078 | $215,190,000 | 2.46% |
SECTORAL ASSET MANAGEMENT INC | 1,851,088 | $57,273,000 | 2.36% |
BB BIOTECH AG | 888,244 | $27,482,000 | 1.42% |
Yakira Capital Management, Inc. | 43,000 | $1,330,000 | 1.19% |